A major breakthrough in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital cancer suppressor protein is frequently lost in several kinds of cancer, resulting https://bookmark-media.com/story22078046/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-approach-for-cancer-treatment